【诺和诺德(NVO.US)更名“Novo”焕新出发 多线突围能否驱散股价阴霾?】智通财经APP获悉,丹麦药企诺和诺德(NVO.US)推出以更短名称“Novo”为核心的全面品牌重塑。公司将在日常品牌宣传中使用“Novo”,但法定名称仍为Novo
Nordisk A/S。原名可追溯至1989年Novo Terapeutisk Laboratorium与Nordisk
Insulinlaboratorium的合并。此次更名围绕“恒久健康,始于当下”(Lasting Health Starts
Now)这一口号展开,旨在将诺和诺德的研究与消费者日常生活更紧密地联系起来。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.